[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363585-105":59,"doc-detail-363585-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","targeting-macrophage-driven-nk-cell-immunosuppression-to-improve-cancer-immunotherapy","Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy","","Natural killer (NK) cells are key effectors of antitumor immunity, yet their cytotoxic function is often weakened by the tumor microenvironment. Tumor-associated macrophages (TAMs), the dominant immune stromal population in solid tumors, reshape NK responses through receptor–ligand interactions, immunosuppressive cytokine signaling, metabolic reprogramming, and immune checkpoint engagement. This review synthesizes bidirectional TAM–NK crosstalk and therapeutic strategies targeting TAMs to restore NK activity, emphasizing spatial niches and translational clinical efforts.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-macrophage-driven-nk-cell-immunosuppression-to-improve-cancer-immunotherapy/363585/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-macrophage-driven-nk-cell-immunosuppression-to-improve-cancer-immunotherapy/363585.png","ImageObject",300,407,{"name":92,"@type":93},"Jasmine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is NK cell activity often impaired in solid tumors?","Question",{"text":113,"@type":114},"NK cell cytotoxicity is frequently compromised by immunosuppressive signals orchestrated by tumor-associated macrophages within the tumor microenvironment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What mechanisms do TAMs use to shape NK cell responses?",{"text":118,"@type":114},"TAMs regulate NK cells through receptor–ligand interactions, immunosuppressive cytokine signaling, metabolic reprogramming, and engagement of immune checkpoint pathways.",{"name":120,"@type":111,"acceptedAnswer":121},"What therapeutic strategies does the review discuss to restore NK cell function?",{"text":122,"@type":114},"Strategies include macrophage depletion and reprogramming, modulation of metabolic and transcriptional pathways, and interventions targeting cytokine networks and immune checkpoints.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},363585,1790821853,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Open access Review  \n Targeting macrophage-driven NK cell  \nimmunosuppression to improve cancer immunotherapy  \nAnna Rita Redavid  ,1,2 Loredana Cifaldi,3 Roberto Bei,3 Emmanuel De Billy,4,5 Doriana Fruci  6  \nTo cite: Redavid AR, Cifaldi L, Bei R, et al. Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy. Journal for ImmunoTherapy of Cancer 2026;14:e014840 . doi:10 . 1136/ jitc-2026-014840  \nAccepted 04 May 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \n1Ospedale Pediatrico Bambino Gesu IRCCS, Rome, Italy 2Translational Research Laboratory of AUSL-IRCCS, Reggio Emilia, Italy 3Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy  \n4Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy  \n5Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy  \n6Bambino Gesu Pediatric Hospital IRCCS, Rome, Italy  \nCorrespondence to  \nDr Doriana Fruci;  \n[doriana.fruci@opbg.net](doriana.fruci@opbg.net)  \nDr Anna Rita Redavid;  \n[annarita.redavid@gmail.com](annarita.redavid@gmail.com)  \nABSTRACT  \nNatural killer (NK) cells are critical effectors of antitumor immunity, however their cytotoxic function is frequently impaired within the tumor microenvironment (TME) .  \nTumor-associated macrophages (TAMs), the most abundant immune stromal population in solid tumors, play a central role in shaping NK cell responses through a broad range of mechanisms, including receptor–ligand interactions, immunosuppressive cytokine signaling, metabolic reprogramming, and engagement of immune checkpoint pathways. Here, we review current insights into the bidirectional crosstalk between TAMs and NK cells and discuss therapeutic strategies aimed at restoring NK cell activity by targeting TAMs. These include macrophage depletion and reprogramming approaches, modulation of metabolic and transcriptional pathways, and interventions targeting cytokine networks and immune checkpoints. We further examine emerging strategies that reshape the TMEto enhance NK-macrophage cooperation, such as induction of inflammatory cell death, modulation of innate immune signaling pathways, and the development of synthetic NK cell engagers. In addition, we highlight the impact of macrophage ontogeny, tissue residency, and spatial organization on NK cell function, emphasizing how distinct microanatomical niches within the TME regulate immune cell interactions and influence therapeutic responses. Finally, we summarize translational advances and ongoing clinical efforts aimed at integrating TAM-targeted therapies with NK cell-based approaches. Collectively, these findings provide a conceptual and mechanistic framework for the rational design of combination immunotherapies that leverage macrophage-NK cell interactions to enhance innate immune responses and improve cancer treatment outcomes.  \nINTRODUCTION  \nThe tumor microenvironment (TME) plays a decisive role in shaping immune responsesand critically determines the success of immunotherapeutic strategies across cancer types.1 While cytotoxic CD8+ T lymphocytes have traditionally been the primary focus of cancer immunotherapy, natural killer (NK) cells have emerged as powerful innate immune effectors capable of eliminating malignant cells through death receptor-mediated apoptosis and the release of cytolytic granules.2 3 Despite  \nthis potential, NK cell activity is frequently compromised in solid tumors, largely due to immunosuppressive signals orchestrated by tumor-associated macrophages (TAMs), the most abundant immune stromal population within the TME.4 5  \nTAMs display pronounced functional plasticity, dynamically adopting proinflammatory or immunosuppressive phenotypesin response to environmental cues.6 7 Their impact on NK cell function is th","cbCaio8kgx0uBsO9","https://ap.wps.com/l/cbCaio8kgx0uBsO9","pdf",1175179,14,"English","# Abstract\n# Introduction\n## Role of TAMs in regulating NK cell function\n## NK cell activation by macrophages","[{\"question\":\"Why is NK cell activity often impaired in solid tumors?\",\"answer\":\"NK cell cytotoxicity is frequently compromised by immunosuppressive signals orchestrated by tumor-associated macrophages within the tumor microenvironment.\"},{\"question\":\"What mechanisms do TAMs use to shape NK cell responses?\",\"answer\":\"TAMs regulate NK cells through receptor–ligand interactions, immunosuppressive cytokine signaling, metabolic reprogramming, and engagement of immune checkpoint pathways.\"},{\"question\":\"What therapeutic strategies does the review discuss to restore NK cell function?\",\"answer\":\"Strategies include macrophage depletion and reprogramming, modulation of metabolic and transcriptional pathways, and interventions targeting cytokine networks and immune checkpoints.\"}]","Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy | PDF",1790151951,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/759c4bba04508ec94268c9cf7912da76.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff2bef3291eb2e97cd23a362288b6219.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4e062f14a1e4ee07b863d1298c6506a.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/627ff6889cb0bf5fde7dc78d74c9a942.webp",980,1306]